Dynavax Technologies
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 408
- Market Cap
- $1.4B
- Introduction
Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by L...
HepB-CpG vs HepB-Alum Vaccine in People With HIV and Prior Vaccine Nonresponse
HepB-CpG vaccine (2 or 3 doses) achieved superior HBV seroprotection in HIV-positive individuals with prior nonresponse to hepatitis B vaccine, compared to conventional HepB-alum vaccine (3 doses).
Related Clinical Trials:
Umoja Biopharma Appoints Scott Myers as Chairman of its Board of Directors
Umoja Biopharma appoints Scott Myers as Chairman of its Board of Directors, succeeding Dieter Weinand who will remain as an advisor. Myers, with extensive biotech experience, aims to transform CAR-T cell therapy delivery.
Tetanus Clinical Trial Pipeline Insights Featuring 20+ Companies
DelveInsight's 'Tetanus Pipeline Insight 2024' report highlights 20+ companies developing 20+ pipeline tetanus drugs, including GC 3111A, KD-370, and TNM 002. Key companies like G C Pharma and KM Biologics are advancing therapies, with promising candidates in various clinical phases. The report also notes a study suggesting tetanus vaccination may reduce Parkinson's disease occurrence.
Contrasting Dynavax Technologies (NASDAQ:DVAX) and PDS Biotechnology (NASDAQ:PDSB)
Dynavax Technologies and PDS Biotechnology are compared based on analyst recommendations, valuation, dividends, institutional ownership, profitability, earnings, and risk. PDS Biotechnology has a higher consensus rating and potential upside, while Dynavax Technologies has higher revenue and earnings. Dynavax Technologies outperforms PDS Biotechnology on 8 of 14 factors.
© Copyright 2024. All Rights Reserved by MedPath